KENZIE CHEW: Open Payments
NPI 1932686300 · MERRIAM, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 14 payments from 8 companies in 2025. Trend: 2023 $272 · 2024 $624 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $115 |
| Boston Scientific Corporation | 3 | $66 |
| Novo Nordisk Inc | 2 | $44 |
| Medtronic, Inc. | 2 | $40 |
| Amgen Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: LEQVIO, WATCHMAN FLX, Wegovy, REPATHA, VERQUVO, AFFERA MAPPING SYSTEM, AURORA EV-ICD MRI SURESCAN, JARDIANCE.
Industry payments across KS — which companies pay providers there.
